KLRC2
| Name | Synonyms | Full Name | RefSeq ID | Description (.pdf) | IGV-img (humangenome) | Sashimi-img (humangenome) | UCSC-img (humangenome) | IGV-img (batgenome) |
|---|---|---|---|---|---|---|---|---|
| KLRC2 | CD159c, NKG2-C, NKG2C,NKG2-C, CD159c | killer cell lectin-like receptor subfamily C, member 2 | NM_002260 | NONE |
Download all snapshots for IGV, UCSC and Sashimi (zip archive)
Description
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The group, designated KLRC (NKG2) are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The KLRC (NKG2) gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells.
This gene is only expressed in Ebola infected cells 23 h after infection, where it also makes a fusion gene with the neighboring KLRC3 gene.
Maximum read counts and DESeq normalized read counts for human and bat cell lines
| Source | Species | Mapping on | Mock3h | Mock7h | Mock23h | EBOV3h | EBOV7h | EBOV23h | MARV3h | MARV7h | MARV23h | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Read_Max | H. sapiens | Genome | 20 | 9 | 7 | 3 | 3 | 50 | 7 | 2 | 7 | |
Read_Max | R. aegyptiacus | Transcriptome | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Read_Max | R. aegyptiacus | Genome | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
DESeq | H. sapiens | Genome | 16.22 | 7.12 | 2.99 | 7.84 | 6.69 | 70.74 | 8.89 | 3.4 | 10.79 | |
DESeq | R. aegyptiacus | Transcriptome | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
DESeq | R. aegyptiacus | Genome | NA | NA | NA | NA | NA | NA | NA | NA | NA |